Golimumab for treating active non-radiographic axial spondyloarthritis (TA497)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 10 January 2018
iFuse for treating chronic sacroiliac joint pain (HTG488)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 30 August 2022Published: 2 October 2018
Ixekizumab for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritis (TA718)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 21 July 2021
Low back pain and sciatica in over 16s: assessment and management (NG59)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 December 2020Published: 30 November 2016
Nusinersen for treating spinal muscular atrophy (TA588)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 July 2019
Omaveloxolone for treating Friedreich’s ataxia in people 16 years and over (terminated appraisal) (TA1061)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 May 2025
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy (HST24)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 19 April 2023
Onasemnogene abeparvovec for treating spinal muscular atrophy (HST15)Product type:GuidanceProgramme:Highly specialised technologies guidanceLast updated: 19 April 2023Published: 7 July 2021
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures (TA279)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 April 2013
Risdiplam for treating spinal muscular atrophy (TA755)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 15 December 2023Published: 16 December 2021
Secukinumab for treating active non-radiographic axial spondyloarthritis (TA719)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 21 July 2021
Spinal injury: assessment and initial management (NG41)Product type:GuidanceProgramme:NICE guidelinePublished: 17 February 2016
Spondyloarthritis in over 16s: diagnosis and management (NG65)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 June 2017Published: 28 February 2017
The EOS 2D/3D imaging system (HTG274)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 October 2011
Tofacitinib for treating active ankylosing spondylitis (TA920)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 October 2023
Upadacitinib for treating active ankylosing spondylitis (TA829)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 September 2022
Upadacitinib for treating active non-radiographic axial spondyloarthritis (TA861)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 February 2023